SCHEMBL12813

SCHEMBL12813

[O]N1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739325 1.00
SCHEMBL2250575 1.00
SCHEMBL129150 0.95
SCHEMBL825746 0.80
SCHEMBL834059 0.80
Diethylamine SCHEMBL27883551 0.76 TP53 (0.42)
Fluoride Ion SCHEMBL816398 0.67 MGLL (0.32)
SCHEMBL23810072 0.61 CYP2D6 (0.33)
SCHEMBL6926105 0.60 MGLL (0.40)
SCHEMBL42220 0.60 MGLL (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3953 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117603175-B Chalcone derivative with benzopyran structure, and preparation method and application thereof 南开大学 2024-08-06 CN claimed
US-20240197711-A1 Combination Therapy for Cancer Treatment REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-06-20 US claimed
CN-112512529-B Cyclopentenepurine derivative or salt thereof 富士胶片株式会社 2024-06-18 CN claimed
WO-2024107393-A1 TRICYCLIC COMPOUNDS SCHRÖDINGER, INC. (US) 2024-05-23 WO claimed
US-20240148895-A1 ANTIBODY-DRUG CONJUGATE EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-09 US claimed
WO-2024083257-A1 SOS1 PROTEIN DEGRADATION AGENT AND USE THEREOF 上海领泰生物医药科技有限公司 2024-04-25 WO claimed
US-20240124419-A1 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-04-18 US claimed
CN-117843567-A Diazaaryl ring substituted benzene derivatives, compositions and uses thereof 康迈迪森(北京)医药科技有限公司 2024-04-09 CN claimed
WO-2024043319-A1 ANTIBODY-DRUG COMPLEX エーザイ・アール・アンド・ディー・マネジメント株式会社 2024-02-29 WO claimed
EP-4328219-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-02-28 EP claimed
US-5510404-A MIXTURE OF OLEFIN POLYMER, HINDERED PIPERDINYLOXY MPOUND COMPOUND, HYPOPHOSPHITE; WEATHER, HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-04-23 US claimed
EP-0488467-B1 Preparation of alkoxyalkanoic acids SHELL INT RESEARCH (NL) 1996-01-31 EP claimed
EP-0448096-B1 Stabilized resin composition SUMITOMO CHEMICAL CO (JP) 1995-11-29 EP claimed
US-5352442-A Topical tempo PROCTOR PETER H (US) 1994-10-04 US claimed
US-5200477-A Having antiagglomerant inert particles with an organomodified polysiloxane present during the vapor phase polymerization to produce synthetic rubbers using a coordination catalyst UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1993-04-06 US claimed
EP-0448096-A1 Stabilized resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-09-25 EP claimed
EP-0230366-B1 METHOD FOR CONTROLLING FOULING OF HYDROCARBON COMPOSITIONS CONTAINING OLEFINIC COMPOUNDS EXXON CHEMICAL PATENTS INC. (US) 1991-03-06 EP claimed
WO-1989011874-A1 MAGNETIC RESONANCE IMAGING HALL LAURENCE DAVID (GB) 1989-12-14 WO claimed
US-4670131-A FREE RADICAL NITROXIDE EXXON CHEMICAL PATENTS INC. (US) 1987-06-02 US claimed
EP-0178168-A2 Process for purification of methacrylic acid AMOCO CORPORATION (US) 1986-04-16 EP claimed